Ken Griffin Edwards Lifesciences Corp Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 681,900 shares of EW stock, worth $51.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

681,900

Previous 475,900 43.29%

Holding current value

$51.4 Million

Previous $44 Million 2.37%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $81.6 Million - $128 Million	1,367,102 Added 218.95%	1,991,503 $131 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $170 Million - $191 Million	-2,020,994 Reduced 76.4%	624,401 $57.7 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $170 Million - $224 Million	2,339,486 Added 764.77%	2,645,395 $253 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $17.5 Million - $22.1 Million	-284,211 Reduced 48.16%	305,909 $23.3 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $40.5 Million - $54.6 Million	584,521 Added 10439.74%	590,120 $40.9 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $80.3 Million - $93.1 Million	-986,634 Reduced 99.44%	5,599 $528,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $38.3 Million - $43.6 Million	515,843 Added 108.28%	992,233 $82.1 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $7.79 Million - $9.98 Million	114,083 Added 31.49%	476,390 $35.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $29.1 Million - $37.9 Million	353,476 Added 4002.67%	362,307 $29.9 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $818,290 - $1.21 Million	-9,460 Reduced 51.72%	8,831 $840,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $1.4 Million - $1.76 Million	-13,713 Reduced 42.85%	18,291 $2.15 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $15.7 Million - $19.3 Million	-147,901 Reduced 82.21%	32,004 $4.15 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $11.3 Million - $13.5 Million	109,725 Added 156.35%	179,905 $20.4 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $56.3 Million - $70.3 Million	-671,205 Reduced 90.53%	70,180 $7.27 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $21.5 Million - $24.8 Million	273,466 Added 58.44%	741,385 $62 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $28.9 Million - $36.7 Million	402,549 Added 615.8%	467,919 $42.7 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $8.66 Million - $11.3 Million	-128,859 Reduced 66.34%	65,370 $5.22 Million
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $16 Million - $21.3 Million	-277,214 Reduced 58.8%	194,229 $13.4 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $20.1 Million - $31 Million	383,045 Added 433.32%	471,443 $88.9 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $68.3 Million - $78.2 Million	-952,600 Reduced 91.51%	88,398 $20.6 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $28.3 Million - $34.7 Million	460,520 Added 79.33%	1,040,998 $76.3 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $13.2 Million - $15.2 Million	-236,258 Reduced 28.93%	580,478 $107 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $39 Million - $52.2 Million	815,215 Added 53597.3%	816,736 $0
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $3.28 Million - $4.03 Million	-70,739 Reduced 97.9%	1,521 $77,000
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $198,750 - $240,186	-4,682 Reduced 6.09%	72,260 $0
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $37.1 Million - $47.4 Million	-998,833 Reduced 92.85%	76,942 $10.7 Million
Q4 2017 Feb 09, 2018	SELL	$33.79 - $39.39 $8.87 Million - $10.3 Million	-262,504 Reduced 19.62%	1,075,775 $121 Million
Q3 2017 Nov 09, 2017	BUY	$36.29 - $38.83 $48.6 Million - $52 Million	1,338,279	1,338,279 $146 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account